Serge Y Fuchs

26PUBLICATIONS
180CO-AUTHORS
Predictive and prognostic markersMolecular targetsTumour immunologyHaematological tumoursInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jun 17, 2026
In vivo CRISPR knockout screen identifies Polr1a as a key driver and a potential therapeutic target for melanoma metastasis.

|Jun 12, 2026
Mono-ADP-ribosylation-driven immunosuppression and cross-resistance to therapy through cancer cell intrinsic and extrinsic mechanisms.

|Apr 10, 2026
SPTBN2 promotes an immunosuppressive tumor microenvironment and cross-resistance to anti-cancer therapies.

Quoc Thang Bui, Raghavendra Basavaraja, Mayura R Dhamdhere

|Apr 15, 2025
Overcoming extracellular vesicle-mediated fratricide improves CAR T cell treatment against solid tumors.

Wenqun Zhong, Zhiyuan Qin, Ziyan Yu

|Oct 26, 2024
RNA Binding Proteins as Potential Therapeutic Targets in Colorectal Cancer.

Vikash Singh, Amandeep Singh, Alvin John Liu

|Aug 21, 2024
Modified C-type natriuretic peptide normalizes tumor vasculature, reinvigorates antitumor immunity, and improves solid tumor therapies.

Zhen Lu, Ioannis Verginadis, Motofumi Kumazoe

Pageof 5

Frequent Collaborators

5 joint publications

J Alan Diehl

4 joint publications

Costas Koumenis

4 joint publications

Ben Z Stanger

4 joint publications

Dmitry I Gabrilovich